Product
Inverse correlated dual-target truncated IL7Ra modified CAR-expressing autologous T-lymphocytes
1 clinical trial
1 indication
Indication
GlioblastomaClinical trial
Phase 1 Study of Autologous Tris-CAR-T Cell Locoregional Immunotherapy for Recurrent GlioblastomaStatus: Recruiting, Estimated PCD: 2024-11-01